Baird’s Athenahealth, Inc. ATHN Stock Holding History

Baird’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-6,865	Closed	-$904K	–	1342
2014 Q3	$904K	Buy	6,865 +4,958	+260%	+$653K	0.01%	687
2014 Q2	$239K	Buy	+1,907	New	+$246K	﹤0.01%	1045

Other funds holding ATHN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baird's ATHN Position: Q4 2014 in Review

Baird sold out of Athenahealth, Inc. (ATHN) in Q4 2014, closing a stake of 6,865 shares — an estimated $904K sold.

Baird first reported a position in ATHN in Q2 2014 and held it in 2 quarters. The position peaked at $904K in Q3 2014. 205 funds tracked by Wall St. Rank hold ATHN as of Q4 2014.

Baird reported no remaining Athenahealth, Inc. position as of Q4 2014 after selling out during the quarter.
Baird sold 6,865 Athenahealth, Inc. shares in Q4 2014, an estimated $904K.
Baird first reported a position in Athenahealth, Inc. in Q2 2014 and held it in 2 quarters.
Baird's Athenahealth, Inc. position peaked at $904K in Q3 2014.
205 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2014.

Based on Baird's 13F filing for Q4 2014, filed 12 Feb 2015.